Skip to main content


Commercial Structure: Creating Launch Plan and Commercial Structure for a Recently Approved Rare Disease Gene Therapy Drug

Read Time
2 minute read


  • A global pharmaceutical client had recently in-licensed a rare disease gene therapy product
  • The objectives of the project were to define an appropriate commercial structure and prepare for the launch outside the US


  • Developed multiple options with regards to commercial structure, with functions at the global, regional or country level
  • Interviewed key stakeholders, defined pros and cons, made recommendation to executive team
  • Developed a consistent high-level launch and commercialization plan and identified a number of short term decisions to be taken


  • A clear structure tailored to the unique needs of this rare disease product allowed the client to rapidly fill key positions
  • Initial outline of launch and commercialization plan rallied stakeholders at various levels to rapidly take on key tasks and responsibilities